En esta página
01CMPX precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
CMPX Compass Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$0,86
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,83mínimo 52 semanas
$6,88máximo 52 semanas
Capitalización Bursátil (MRQ)
$154M
Ingresos
$0
tus insignias
Rango 52S
$1–$7
Calificación del Analista
BUY
Precio Objetivo
$5
P/E
·
ROE
-45.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CMPX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.86
Capitalización Bursátil (MRQ)
$154M
Ingresos
$0
ROE
-45.9%
Rango 52S
$1–$7
CMPX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02023-12-31 → 2025-12-31
Flujo de caja libre$-49M2020-12-31 → 2025-12-31
Margen neto·2024-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CMPX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/C (MRQ) | 0.9promedio 5A ≈2.7 | ≈2.7 | 2.7 | Valor razonable | |
| Precio / FCF (TTM) | -2.7promedio 5A ≈-12.5 | ≈-12.5 | · | · | |
| Precio / Flujo de Caja (TTM) | -2.7promedio 5A ≈-12.7 | ≈-12.7 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.8promedio 5A ≈2.7 | ≈2.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CMPX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -36.9%promedio 5A ≈-39.2% | ≈-39.2% | -34.2% | En línea | |
| ROE | -45.9%promedio 5A ≈-47.5% | ≈-47.5% | -59.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CMPX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 11.2promedio 5A ≈15.1 | ≈15.1 | 8.8 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 15.0promedio 5A ≈14.8 | ≈14.8 | 8.6 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | CMPX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.1 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.6%
Próximo informe
Nov 03, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.13 | $-0.11 | -17.6% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.10 | $-0.10 | 0.10% |
| 31 de diciembre de 2025 | $-0.09 | $-0.09 | 2.4% | |
| 30 de septiembre de 2025 | $-0.08 | $-0.14 | 43.0% | |
| 30 de junio de 2025 | $-0.14 | $-0.12 | -12.3% | |
| 31 de marzo de 2025 | $-0.12 | $-0.11 | -6.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $850.0K | $0 | |
| R&D Expense | $56M | $42M | $38M | |
| SG&A Expense | $17M | $15M | $12M | |
| Operating Expenses | $73M | $57M | $50M | |
| Operating Income | $-73M | $-57M | $-50M | |
| Interest Income | $6M | $7M | $8M | |
| Other Non-op | $6M | $7M | $8M | |
| Pretax Income | · | · | $-42M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-66M | $-49M | $-42M | |
| EPS (Basic) | $-0.42 | $-0.36 | $-0.33 | |
| Shares (Basic) | 157,695,000 | 137,384,000 | 127,027,000 | |
| Shares (Diluted) | · | 137,400,000 | · | |
| EBITDA | $-73M | $-57M | $-50M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $31M | $43M | $24M | |
| Short-term Investments | $178M | $83M | $128M | |
| Prepaid Expense | $913.0K | $6M | $1M | |
| Current Assets | $210M | $133M | $154M | |
| PP&E (Net) | $102.0K | $353.0K | $898.0K | |
| PP&E (Gross) | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $6M | $6M | |
| Other Non-current Assets | · | $568.0K | $320.0K | |
| Total Assets | $220M | $140M | $157M | |
| Accounts Payable | $2M | $2M | $4M | |
| Accrued Liabilities | $11M | $6M | $3M | |
| Current Liabilities | $14M | $9M | $8M | |
| Capital Leases | $9M | $6M | $536.0K | |
| Total Liabilities | $23M | $15M | $8M | |
| Common Stock | $18.0K | $14.0K | $13.0K | |
| Retained Earnings | $-431M | $-365M | $-315M | |
| AOCI | $280.0K | $210.0K | $37.0K | |
| Stockholders' Equity | $197M | $125M | $149M | |
| Liabilities + Equity | $220M | $140M | $157M | |
| Shares Outstanding | 178,324,000 | 137,820,000 | 127,668,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $276.0K | $589.0K | $699.0K | |
| Stock-based Comp | $8M | $9M | $6M | |
| Operating Cash Flow | $-49M | $-45M | $-41M | |
| CapEx | $25.0K | $44.0K | $30.0K | |
| Investing Cash Flow | $-93M | $47M | $27M | |
| Stock Issued | $138M | $18M | $3M | |
| Net Stock Activity | $138M | $18M | $3M | |
| Financing Cash Flow | $130M | $17M | $3M | |
| Net Change in Cash | $-13M | $19M | $-11M | |
| Free Cash Flow | $-49M | $-45M | $-41M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -6661.8% | · | |
| Net Margin | · | -5808.8% | · | |
| EBITDA Margin | · | -6661.8% | · | |
| ROA | -36.9% | -33.2% | -23.8% | |
| ROE | -45.9% | -37.5% | -27.5% | |
| ROIC | · | · | -33.9% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.0 | 15.0 | 19.7 | |
| Quick Ratio | 15.0 | 14.3 | 19.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $1.10 | $0.91 | $1.16 | |
| Cash / Share | $0.17 | $0.32 | $0.19 |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $850.0K | $0 | |
| Net Income TTM | $-66M | $-49M | $-42M | |
| Market Cap | $958M | $200M | $199M | |
| P/S | · | 235.1 | · | |
| P/B | 4.9 | 1.6 | 1.3 | |
| P / Tangible Book | 4.9 | 1.6 | 1.3 | |
| P / Cash Flow | -19.5 | -4.5 | -4.9 | |
| P / FCF | -19.5 | -4.5 | -4.9 |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $850.0K | · | $0 | $0 | $0 | |
| R&D Expense | · | $13M | $14M | $13M | $16M | $13M | $13M | $9M | $11M | $10M | · | · | · | |
| SG&A Expense | $7M | $7M | $4M | $3M | $5M | $5M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $27M | $20M | $18M | $16M | $21M | $18M | $17M | $12M | $16M | $13M | $15M | $12M | $13M | |
| Operating Income | $-27M | $-20M | $-18M | $-16M | $-21M | $-18M | $-17M | $-12M | $-15M | $-13M | $-15M | $-12M | $-13M | |
| Interest Income | · | · | · | · | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Pretax Income | · | · | · | · | · | $-17M | · | · | $-13M | $-11M | · | $-10M | $-11M | |
| Income Tax | · | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-18M | $-16M | $-14M | $-20M | $-17M | $-15M | $-10M | $-13M | $-11M | $-13M | $-10M | $-11M | |
| EPS (Basic) | $-0.13 | $-0.10 | $-0.08 | $-0.08 | $-0.14 | $-0.12 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.09 | |
| Shares (Basic) | 186,798,000 | 186,400,000 | · | 168,782,000 | 138,282,000 | 138,236,000 | · | 137,589,000 | 137,589,000 | 136,608,000 | · | 127,424,000 | 126,729,000 | |
| Shares (Diluted) | · | · | · | · | · | 138,200,000 | · | 137,600,000 | · | · | · | · | · | |
| EBITDA | $-27M | $-20M | · | $-16M | $-21M | $-18M | · | $-12M | $-15M | $-13M | · | $-12M | $-13M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $55M | $31M | $46M | $23M | $41M | $43M | $37M | $19M | $24M | $24M | $30M | $19M | |
| Short-term Investments | $144M | $140M | $178M | $174M | $78M | $72M | $83M | $99M | $127M | $133M | $128M | $133M | $149M | |
| Prepaid Expense | $1M | $1M | $913.0K | $1M | $5M | $12M | $6M | $6M | $7M | $2M | $1M | $3M | $7M | |
| Current Assets | $181M | $196M | $210M | $221M | $106M | $124M | $133M | $141M | $154M | $159M | $154M | $167M | $175M | |
| PP&E (Net) | $324.0K | $169.0K | $102.0K | $119.0K | $131.0K | $231.0K | $353.0K | $493.0K | $592.0K | $744.0K | $898.0K | $1M | $1M | |
| PP&E (Gross) | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | |
| Total Assets | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Accounts Payable | $3M | $906.0K | $2M | $3M | $3M | $2M | $2M | $960.0K | $1M | $854.0K | $4M | $2M | $724.0K | |
| Accrued Liabilities | $12M | $8M | $11M | $9M | $11M | $13M | $6M | $3M | $7M | $2M | $3M | $6M | $8M | |
| Current Liabilities | $16M | $10M | $14M | $12M | $14M | $15M | $9M | $4M | $10M | $4M | $8M | $9M | $10M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $6M | $6M | $6M | $0 | $189.0K | $536.0K | $869.0K | $1M | |
| Total Liabilities | $24M | $19M | $23M | $22M | $23M | $21M | $15M | $11M | $10M | $4M | $8M | $10M | $11M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | |
| Retained Earnings | $-475M | $-449M | $-431M | $-415M | $-401M | $-381M | $-365M | $-350M | $-339M | $-326M | $-315M | $-302M | $-292M | |
| AOCI | $-251.0K | $-159.0K | $280.0K | $274.0K | $208.0K | $190.0K | $210.0K | $486.0K | $-91.0K | $-90.0K | $37.0K | $-430.0K | $-507.0K | |
| Stockholders' Equity | $166M | $186M | $197M | $210M | $93M | $110M | $125M | $138M | $146M | $157M | $149M | $160M | $168M | |
| Liabilities + Equity | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Shares Outstanding | 180,088,000 | 180,088,000 | 178,324,000 | 177,572,000 | 138,282,000 | 138,282,000 | 137,820,000 | 137,589,000 | 137,589,000 | 137,589,000 | 127,668,000 | 127,445,000 | 127,388,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21.0K | $15.0K | $17.0K | $19.0K | $100.0K | $140.0K | $140.0K | $143.0K | $152.0K | $154.0K | $161.0K | $164.0K | $180.0K | |
| Stock-based Comp | $5M | $5M | $2M | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-15M | $-17M | $-13M | $-11M | $-12M | $-13M | $-9M | $-11M | $-11M | $-14M | $-12M | $-6M | $-10M | |
| CapEx | $176.0K | $82.0K | $0 | $7.0K | $0 | $18.0K | $0 | $44.0K | $0 | $0 | $9.0K | $10.0K | $11.0K | |
| Investing Cash Flow | $-5M | $38M | $-3M | $-95M | $-6M | $12M | $15M | $29M | $6M | $-4M | $6M | $17M | $-667.0K | |
| Stock Issued | · | · | $0 | $138M | $0 | $0 | $0 | $0 | $0 | $18M | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $18M | · | · | · | |
| Financing Cash Flow | $0 | $3M | $1M | $129M | $0 | $-815.0K | $-94.0K | $-2.0K | $1.0K | $17M | $-158.0K | $21.0K | $3M | |
| Net Change in Cash | $-20M | $25M | $-16M | $23M | $-18M | $-2M | $6M | $18M | $-4M | $-554.0K | $-6M | $11M | $-8M | |
| Free Cash Flow | · | $-17M | · | · | · | $-13M | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| ROA | -16.4% | -10.9% | · | -7.5% | -14.6% | -11.4% | · | -6.6% | -7.8% | -6.2% | · | -6.7% | -7.1% | |
| ROE | -19.4% | -12.3% | · | -8.2% | -16.6% | -12.4% | · | -7.0% | -8.3% | -6.5% | · | -7.2% | -7.6% | |
| ROIC | · | · | · | · | · | -16.3% | · | · | -10.3% | -8.1% | · | -7.4% | -7.9% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.2 | 19.0 | · | 17.8 | 7.7 | 8.3 | · | 31.8 | 16.2 | 40.7 | · | 18.3 | 18.1 | |
| Quick Ratio | 11.2 | 18.9 | · | 17.7 | 7.3 | 7.6 | · | 30.5 | 15.4 | 40.1 | · | 17.9 | 17.4 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.92 | $1.04 | · | $1.18 | $0.67 | $0.80 | · | $1.01 | $1.06 | $1.14 | · | $1.26 | $1.32 | |
| Cash / Share | $0.20 | $0.31 | · | $0.26 | $0.17 | $0.30 | · | $0.27 | $0.14 | $0.17 | · | $0.24 | $0.15 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-73M | $-68M | · | $-66M | $-62M | $-55M | · | $-48M | $-47M | $-45M | · | $-41M | $-43M | |
| Market Cap | $394M | $953M | · | $622M | $360M | $263M | · | $253M | $138M | $272M | · | $251M | $405M | |
| P/B | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Tangible Book | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Cash Flow | · | -55.2 | · | · | · | -19.9 | · | · | · | -19.6 | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $850.0K | $0 | · | · |
| Margen Operativo % | · | -6661.8% | · | · | · |
| Beneficio neto | $-66M | $-49M | $-42M | $-39M | $-82M |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | · | · | · | 0.0 |
| Ratio corriente | 15.0 | 15.0 | 19.7 | 12.0 | 13.8 |
| Ratio Rápido | 15.0 | 14.3 | 19.5 | 11.5 | 13.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-49M | $-45M | $-41M | $-34M | $-21M |
Propietarios institucionales (13F) 225 declarantes · $404.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
225
Valor en tenencia
$404.9M
Nuevas posiciones
65
Posiciones cerradas
44
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 65 (+9 vs trimestre anterior) | 44 (+25 vs trimestre anterior) | 85 (+13 vs trimestre anterior) | 46 (-1 vs trimestre anterior) | -7.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43 219 768 | 8 048 374 | 10,67% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $39 399 813 | 17 990 782 | 9,73% | Acciones |
| ORBIMED ADVISORS LLC | $33 331 787 | 15 219 994 | 8,23% | Acciones |
| MONTANOVA CAPITAL, LLC | $30 881 538 | 14 101 159 | 7,63% | Acciones |
| BlackRock, Inc. | $24 707 100 | 11 281 781 | 6,10% | Acciones |
| STATE STREET CORP | $21 798 500 | 9 953 653 | 5,38% | Acciones |
| ENAVATE SCIENCES GP, LLC | $17 056 049 | 7 788 150 | 4,21% | Acciones |
| Vivo Capital, LLC | $16 987 961 | 7 757 060 | 4,20% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $13 400 133 | 6 118 782 | 3,31% | Acciones |
| Palo Alto Investors LP | $12 771 670 | 5 831 813 | 3,15% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $10 322 011 | 4 713 247 | 2,55% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $8 357 450 | 3 815 189 | 2,06% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 258 560 | 3 771 032 | 2,04% | Acciones |
| Qube Research & Technologies Ltd | $8 075 601 | 3 687 489 | 1,99% | Acciones |
| Blue Owl Capital Holdings LP | $7 936 726 | 3 624 076 | 1,96% | Acciones |
| CITADEL ADVISORS LLC | $7 819 776 | 3 570 674 | 1,93% | Acciones |
| GOLDMAN SACHS GROUP INC | $7 732 890 | 3 531 000 | 1,91% | Acciones |
| Rock Springs Capital Management LP | $7 719 595 | 3 524 929 | 1,91% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $7 685 011 | 3 509 137 | 1,90% | Acciones |
| Birchview Capital, LP | $3 668 250 | 1 675 000 | 0,91% | Acciones |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $3 066 000 | 1 400 000 | 0,76% | Acciones |
| Fisher Asset Management, LLC | $3 048 238 | 1 391 890 | 0,75% | Acciones |
| ROYCE & ASSOCIATES LP | $2 927 548 | 1 336 780 | 0,72% | Acciones |
| FMR LLC | $2 654 709 | 1 212 196 | 0,66% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2 598 435 | 1 186 500 | 0,64% | Acciones |
| NORTHERN TRUST CORP | $2 498 603 | 1 140 914 | 0,62% | Acciones |
| Atle Fund Management AB | $2 296 418 | 1 048 593 | 0,57% | Acciones |
| Nuveen, LLC | $2 213 130 | 1 010 562 | 0,55% | Acciones |
| Squarepoint Ops LLC | $2 206 440 | 1 007 507 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 192 054 | 1 000 938 | 0,54% | Acciones |
| Blackstone Inc. | $1 970 860 | 899 936 | 0,49% | Acciones |
| FIRST TRUST ADVISORS LP | $1 767 338 | 807 004 | 0,44% | Acciones |
| JPMORGAN CHASE & CO | $1 705 102 | 789 399 | 0,42% | Acciones |
| KVP Capital Advisors, LP | $1 688 490 | 771 000 | 0,42% | Acciones |
| MORGAN STANLEY | $1 610 058 | 735 186 | 0,40% | Acciones |
| CITIGROUP INC | $1 563 457 | 713 907 | 0,39% | Acciones |
| UBS Group AG | $1 560 951 | 712 763 | 0,39% | Acciones |
| Burkehill Global Management, LP | $1 533 000 | 700 000 | 0,38% | Acciones |
| Point72 Asset Management, L.P. | $1 503 604 | 686 577 | 0,37% | Acciones |
| ACUTA CAPITAL PARTNERS, LLC | $1 303 516 | 595 213 | 0,32% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 241 553 | 566 919 | 0,31% | Acciones |
| CM Management, LLC | $1 204 500 | 550 000 | 0,30% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 184 772 | 541 178 | 0,29% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $1 147 072 | 523 777 | 0,28% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $856 345 | 161 880 | 0,21% | Acciones |
| Artia Global Partners LP | $839 208 | 383 200 | 0,21% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $829 324 | 378 687 | 0,20% | Acciones |
| ArrowMark Colorado Holdings LLC | $798 785 | 364 742 | 0,20% | Acciones |
| Bank of New York Mellon Corp | $768 760 | 351 032 | 0,19% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $738 706 | 139 642 | 0,18% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Commander Aggregator, LP, Enavate Sciences, LP, Enavate Sciences GP, LLC, Enavate Sciences Holdings, LLC | 18 de agosto de 2025 | 4,50% | Enmienda | · | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×7 presentaciones | 15 de agosto de 2025 | 8,90% | Enmienda | · | SEC |
| Persona informante no revelada | 14 de noviembre de 2022 | · | Presentación inicial | Inversión pasiva | SEC |
| Philip Ferneau, Vox Health Fund, L.P., Borealis Capital Partners IV, LLC, Borealis Granite Fund, L.P., Borealis Capital Partners III, LLC | 26 de junio de 2020 | · | Presentación inicial | · | SEC |
| Thomas J. Schuetz | 26 de junio de 2020 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 19 insiders · 8 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Thomas J. Schuetz | CHIEF EXECUTIVE OFFICER | 8 de febrero de 2026 F | 6 603 336 | 0 | 0 | $0 |
| Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER | 8 de febrero de 2024 F | 3 124 426 | 0 | 0 | $0 |
| Barry Shin | CFO | 2 de enero de 2026 A | 525 000 | 0 | 0 | $0 |
| Neil Lerner | Chief Accounting Officer | 1 de octubre de 2026 P | 420 000 | 3 | 0 | $49 600 |
| Jonathan Anderman | General Counsel | 29 de abril de 2026 P | 196 000 | 1 | 0 | $47 250 |
| Arjun Prasad | Chief Commercial Officer | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| Susan Kalled | Chief Scientific Officer | 18 de febrero de 2022 A | · | 0 | 0 | $0 |
| James P Boylan | Consejero | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| Philip Ferneau | Consejero | 2 de enero de 2026 A | 400 280 | 0 | 0 | $0 |
| Ellen Chiniara | Consejero | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| GORDON CARL L | Consejero | 2 de enero de 2026 A | 0 | 0 | 0 | $0 |
| Mary Ann Gray | Consejero | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| Richard S Lindahl | Consejero | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| David M Wurzer | Consejero | 8 de febrero de 2023 A | · | 0 | 0 | $0 |
| Brett Kaplan | Consejero | 18 de febrero de 2022 A | · | 0 | 0 | $0 |
| Stephen P Squinto | Consejero | 18 de febrero de 2022 A | · | 0 | 0 | $0 |
| Miranda Jayne Toledano | Consejero | 25 de junio de 2021 A | 1 791 549 | 0 | 0 | $0 |
| Julie Sunderland | Consejero | 19 de junio de 2020 P | 2 502 025 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 20 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,63% | 153 110 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,09% | 232 413 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 445 711 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,03% | 3 175 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 114 090 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 754 118 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 3 395 394 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 62 629 NS | 31 de julio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 37 125 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 101 119 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 166 283 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 244 937 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 34 242 SH | 3 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 19 635 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13 305 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 793 659 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 190 754 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11 073 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 257 838 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 1 205 272 SH | 11 de septiembre de 2026 | Diario |
CMPX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 21 analistas
COMPRA
Objetivo mediano
$6.00
+600,4%
9 42,9%
Compra fuerte
10 47,6%
Compra
2 9,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
11 analistas · 2026-10-01Objetivo medio $5.45 +536,7%
← Por Debajo de Todos los Objetivos
Precio Actual $0.86
Mín$1.00
Media$5.45
Máx$12.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CMPX | $958M | · | · | · | -45.9% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026